| Karen Esther Borofsky, MD | |
|
136 Mountain View Blvd, Basking Ridge, NJ 07920-3444 | |
| (908) 542-3100 | |
| (908) 542-3215 |
| Full Name | Karen Esther Borofsky |
|---|---|
| Gender | Female |
| Speciality | Radiology - Radiation Oncology |
| Location | 136 Mountain View Blvd, Basking Ridge, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710991526 | NPI | - | NPPES |
| 0089460 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 25MA07850700 (New Jersey) | Primary |
| Entity Name | Memorial Radiation Oncology Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235109224 PECOS PAC ID: 8527957091 Enrollment ID: O20040312000532 |
News Archive
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
Since the first AIDS case was documented twenty-five years ago by the Centers for Disease Control and Prevention this June 5th, a generation of young people has grown up never knowing a time without the disease.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for cabazitaxel solution; IV (infusion) in 60 mg/1.5 mL (40 mg/mL) strength, a generic version of Jevtana® by Sanofi.
The United States Surgeon General recently issued a report that adolescents' use of electronic cigarettes has more than tripled since 2011. As recently as 2010, e-cigarettes were rare, but in 2015, 40 percent of high school students said they had used e-cigarettes at least once and 16 percent reported that they used such products in the past 30 days.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen Esther Borofsky, MD 136 Mountain View Blvd, Basking Ridge, NJ 07920-3444 Ph: (908) 542-3100 | Karen Esther Borofsky, MD 136 Mountain View Blvd, Basking Ridge, NJ 07920-3444 Ph: (908) 542-3100 |
News Archive
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
Since the first AIDS case was documented twenty-five years ago by the Centers for Disease Control and Prevention this June 5th, a generation of young people has grown up never knowing a time without the disease.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for cabazitaxel solution; IV (infusion) in 60 mg/1.5 mL (40 mg/mL) strength, a generic version of Jevtana® by Sanofi.
The United States Surgeon General recently issued a report that adolescents' use of electronic cigarettes has more than tripled since 2011. As recently as 2010, e-cigarettes were rare, but in 2015, 40 percent of high school students said they had used e-cigarettes at least once and 16 percent reported that they used such products in the past 30 days.
› Verified 2 days ago
Helen L Sidebotham, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 136 Mountain View Blvd, Basking Ridge, NJ 07920 Phone: 908-542-3000 | |
Linda R Aboody, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 136 Mountain View Blvd, Basking Ridge, NJ 07920 Phone: 908-542-3200 | |
Tammy Huang, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 136 Mountainview Blvd, Basking Ridge, NJ 07920 Phone: 212-639-2000 |